Discover
RCEL
AVITA Medical, Inc.
11.02
2 x 7.29
2 x 13.05
bid
ask
-
0.20
1.78%
2 @ 07:33 PM
10.91 -0.11 (1.00%)
| Ytd | 219.42% | |
| 1y | 98.92% |
10.72
day range
11.20
3.27
52 week range
11.22
| Open | 11.15 | Prev Close | 11.22 | Low | 10.72 | High | 11.20 | Mkt Cap | 340.81M |
| Vol | 359.08K | Avg Vol | 469.18K | EPS | -1.44 | P/E | N/A | Forward P/E | -14.33 |
| Beta | 1.54 | Short Ratio | 10.24 | Inst. Own | 23.45% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 11-05 | 50-d Avg | 7.59 | 200-d Avg | 5.02 | 1yr Est | 16.81 |
| Income Statement | |||
| Total Revenue | 21.70M | ||
| Revenues (USD) | 21.70M | ||
| Cost of Revenue | 3.94M | ||
| Gross Profit | 17.77M | ||
| Operating Expenses | 24.62M | ||
| Research and Development Expense | 5.08M | ||
| Selling, General and Administrative Expense | 19.54M | ||
| Operating Income | -6.85M | ||
| Interest Expense | 1.46M | ||
| Income Tax Expense | 33.00K | ||
| Net Income | -7.66M | ||
| Net Income Common Stock | -7.66M | ||
| Net Income Common Stock (USD) | -7.66M | ||
| Consolidated Income | -7.66M | ||
| Earnings per Basic Share | -0.25 | ||
| Earnings per Basic Share (USD) | -0.25 | ||
| Earnings per Diluted Share | -0.25 | ||
| Earning Before Interest & Taxes (EBIT) | -6.17M | ||
| Earning Before Interest & Taxes (USD) | -6.17M | ||
| Weighted Average Shares | 30.75M | ||
| Weighted Average Shares Diluted | 30.75M | ||
| Balance Sheet | |||
| Cash and Equivalents | 9.14M | ||
| Cash and Equivalents (USD) | 9.14M | ||
| Investments | 2.00M | ||
| Investments Current | 2.00M | ||
| Trade and Non-Trade Receivables | 9.87M | ||
| Current Assets | 28.39M | ||
| Property, Plant & Equipment Net | 10.33M | ||
| Total Assets | 47.78M | ||
| Debt Current | 46.66M | ||
| Total Debt | 48.48M | ||
| Current Liabilities | 68.71M | ||
| Debt Non-Current | 1.82M | ||
| Total Liabilities | 75.61M | ||
| Accumulated Retained Earnings (Deficit) | -426.67M | ||
| Accumulated Other Comprehensive Income | -82.00K | ||
| Shareholders Equity | -27.84M | ||
| Shareholders Equity (USD) | -27.84M | ||
| Assets Non-Current | 19.38M | ||
| Total Debt (USD) | 48.48M | ||
| Deferred Revenue | 273.00K | ||
| Goodwill and Intangible Assets | 5.25M | ||
| Inventory | 5.29M | ||
| Liabilities Non-Current | 6.90M | ||
| Trade and Non-Trade Payables | 6.42M | ||
| Cash Flow | |||
| Depreciation, Amortization & Accretion | 845.00K | ||
| Net Cash Flow from Financing | 437.00K | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | 830.00K | ||
| Capital Expenditure | -108.00K | ||
| Issuance (Purchase) of Equity Shares | 437.00K | ||
| Net Cash Flow from Investing | 3.89M | ||
| Net Cash Flow - Investment Acquisitions and Disposals | 4.00M | ||
| Net Cash Flow from Operations | -3.50M | ||
| Share Based Compensation | 1.99M | ||